Management of the Lower Ureter in Nephroureterectomy Audit
Management of the lower end of ureter in nephroureterectomy varies widely because there is no clear evidence as to which procedure offers the best cancer control. The reason for this lack of evidence would appear to be difficulty in recruiting and undertaking a surgical trial in this group of patients.
The aims of this audit are:
- to determine which surgical technique offers the best cancer control in terms of survival and recurrence;
- to capture patient profiles at entry;
- to determine whether the different procedures are performed without significant morbidity; and
- to establish the recurrence and survival rates of patients who underwent procedures between 1 January 2017 and 31 December 2019
Data on patients who underwent nephroureterectomy procedures between 1 January 2017 and 31 December 2019 is already captured in the BAUS nephrectomy registry. A small number of additional fields have been added to this dataset for surgeons to go back and complete, as well as entering follow-up data for the 2017 - 2019 patients who underwent this procedure.
The audit will run until January 2022 when all patients should have a minimum of 2 years of follow up.
If you have any queries about this audit please telephone Louisa Hermans, BAUS Programme Manager, on +44 (0)208 051 6708 or send her an email by clicking here.